Dr. Reddy's Laboratories, Inc. 2023-03-01 Health serious FDA
Health · FDA · Recall #FDA-D-0330-2023
Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's… Recall
Issued March 1, 2023 · Dr. Reddy's Laboratories, Inc.
In March 2023, Dr. Reddy's Laboratories, Inc. recalled the Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
What you should do
- 1 Stop using Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Dr. Reddy's Laboratories, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Dr. Reddy's Laboratories, Inc.
- Category
- Health
- Recall date
- March 1, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0330-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Dr. Reddy's Laboratories, Inc. has 17 recalls in our database, including 3 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.